SUBSCRIBE
SUBSCRIBE

Alnylam Pharmaceuticals

NEWS
Biotech Bay
The Day In Review: Cephalon, Inc. Wins Second Indication For Fento
October 11, 2006
 · 
1 min read
The Day In Review: News On Multiple Sclerosis Drugs
September 28, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) Pays $515 Million For AnorMED
September 26, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Threshold Pharmaceuticals, Inc. Crushed On Trial Failure
July 17, 2006
 · 
1 min read
Biotech Beach
The Day In Review: MGI PHARMA, INC. Sells Ex-US Dacogen Rights
July 6, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Merck & Co., Inc. Gobbles Up Two Biotechs
May 9, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Biotechs Update Hepatitis C News
May 1, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Biotech IPOs Get Chilly Reception
April 12, 2006
 · 
1 min read
Genetown
Scientists “Silence Gene” To Slash Cholesterol Levels
March 30, 2006
 · 
1 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Policy
Alnylam Completes Rolling Submission of New Drug Application to the US FDA and Submits Marketing Authorization Application to the European Medicines Agency for Lumasiran for the Treatment of Primary Hyperoxaluria Type 1
April 7, 2020
 · 
11 min read
Business
Alnylam and Dicerna Form RNAi Therapeutics Collaboration on Alpha-1 Antitrypsin Deficiency-Associated Liver Disease and Complete Cross-License Agreement for Primary Hyperoxaluria Programs
April 6, 2020
 · 
18 min read
Business
Vir and Alnylam Expand Collaboration to Advance Investigational RNAi Therapeutics Targeting Host Factors for the Treatment of COVID-19
April 2, 2020
 · 
12 min read
Business
Vir and Alnylam Expand Collaboration to Advance RNAi Therapeutics for the Treatment of Coronavirus Infection, Including COVID-19
March 4, 2020
 · 
10 min read
Genetown
Alnylam Announces Approval of GIVLAARI® (givosiran) in the European Union for the Treatment of Acute Hepatic Porphyria (AHP) in Adults and Adolescents
March 3, 2020
 · 
12 min read
Genetown
Alnylam Announces Changes to its Board of Directors
February 27, 2020
 · 
8 min read
Genetown
Alnylam Announces Approval in Brazil of ONPATTRO® for the Treatment of Hereditary ATTR Amyloidosis with Polyneuropathy
February 26, 2020
 · 
10 min read
Genetown
Alnylam to Webcast Presentations at Upcoming March 2020 Investor Conferences
February 25, 2020
 · 
2 min read
Genetown
Alnylam to Webcast Presentation at 9th Annual SVB Leerink Global Healthcare Conference
February 20, 2020
 · 
2 min read
Drug Development
Alnylam Completes Enrollment of HELIOS-A Phase 3 Study of Vutrisiran for the Treatment of hATTR Amyloidosis with Polyneuropathy
February 18, 2020
 · 
9 min read
Load More